Table 1 Fine-mapping of PSC risk loci

From: Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci

Region

Fine-mapping

Chr

Candidate gene

Lead GWAS SNP

Position (b37)

Signal

SNP PPmax

Position (b37)

PP Causal

Credible set size

1

MMEL1

rs3748816

2526745

1

rs61763697

2810791

0.07

62

2

BCL211

rs72837826

111933001

1

rs72837826

111933001

0.18

12

2

CD28

rs7426056

204612058

1

rs5837875

204647878

0.19

6

2

rs231799

204707417

0.17

24

3

MST1

rs3197999

49721532

1

rs11716895

49762779

0.11

13

2

rs13083791

49721798

0.07

122

3

FOXP1

rs80060485

71153890

1

rs80060485

71153890

0.99

1

2

rs36023390

71523093

0.14

2

4

IL2-IL21

rs13140464

123499745

1

rs13119723

123218313

0.09

50

6

BACH2

rs56258221

91030441

1

rs7750271

91036225

0.20

12

10

IL2RA

rs4147359

6108439

1

rs4147359

6108439

0.46

5

11

CCDC88B

rs663743

64107735

1

rs35247680

63884747

0.61

2

2

rs663743

64107735

0.41

2

12

SH2B3

rs3184504

111884608

1

rs3184504

111884608

0.99

1

16

CLEC16A

rs725613

11169683

1

rs725613

11169683

0.16

12

18

CD226

rs1788097

67543688

1

rs1610555

67543147

0.08

44

19

PRKD2

rs313839

47221557

1

rs313839

47221557

0.23

14

21

ETS2

rs2836883

40466744

1

rs4817988

40468838

0.58

10

21

UBASH3A

rs1893592

43855067

1

rs1893592

43855067

0.62

5

  1. Fine-mapped loci (PP of casuality \(\ge\)0.5) shown in bold.